West Virginia House Bill HB2765

West Virginia 2025 Regular Session

• Introduced: 2/21/25
• Refer: 2/21/25

Caption

Relating to certification of a patient’s eligibility for medical cannabis

Summary

House Bill 2765 would amend West Virginia’s Medical Cannabis Act to broaden who may certify a patient for medical cannabis and to revise the eligibility standard for certification. The bill’s stated purpose is to give attending physicians authority to use their professional judgment to certify that a patient’s serious medical condition would benefit from medical cannabis, rather than relying only on the existing enumerated-condition framework. It also updates the statutory definition of “serious medical condition” to include a list of qualifying diagnoses and adds language tying eligibility to a medical doctor’s professional judgment that cannabis would be beneficial. The bill retains and restates many core definitions in the medical cannabis chapter, including patient, practitioner, dispensary, grower, processor, permit, identification card, and terminal illness. It would affect the certification process for patients seeking access to medical cannabis by making the physician’s clinical assessment more central to eligibility. In practical terms, it could expand access for patients whose conditions are not expressly listed or whose symptoms are best evaluated case by case, while still keeping the program within the state’s regulated medical cannabis system.

Impact

HB2765 would amend §16A-2-1 of the West Virginia Code, which governs definitions and eligibility-related terms under the Medical Cannabis Act. The main legal effect is to shift certification authority toward attending physicians’ professional judgment and to revise the statutory description of qualifying serious medical conditions for medical cannabis access. This could broaden the pool of patients eligible for certification and potentially increase demand for registry enrollment, identification cards, and dispensary access under the state program.

Sentiment

Based on the bill text alone and the absence of committee transcripts or recorded votes, the bill appears to be framed as a patient-access and physician-discretion measure rather than a restrictive regulatory change. The sponsors’ stated purpose suggests support for giving clinicians more flexibility in treating serious conditions with medical cannabis. There is no recorded vote history or committee debate in the provided materials to indicate formal support or opposition, but the bill’s direction implies a generally pro-access posture.

Contention

The likely point of contention is the degree of discretion given to physicians versus the state’s interest in maintaining a tightly defined medical cannabis program. Supporters would likely favor broader clinical judgment and easier access for patients with serious or intractable conditions, while opponents may worry that loosening eligibility standards could expand the program beyond intended limits, reduce consistency in certification, or complicate oversight. Another possible issue is whether the revised definition of serious medical condition is sufficiently specific to prevent uneven application across practitioners.